Our aim is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology clinical trials and studies, and behavioral-social sciences. The rationale behind this program is to produce researchers who can excel in the increasingly complex and specialized environments required for future cancer research. The IDTG is a highly competitive and demanding training program. Trainees work closely with two mentors who provide distinct, complementary areas of expertise (for example, by studying basic molecular and cellular mechanisms of neoplasia in combination with epidemiological analyses of related risk factors;or by participating in clinical research studies while studying behavioral or environmental factors that influence therapeutic outcomes). Our trainee projects transcend the traditional boundaries separating the molecular and cellular, clinical, epidemiologic and social cancer sciences. As a result, the IDTG and Program differ fundamentally in focus, goals and training plans from other pre- and post-Doctoral training programs in the Seattle biomedical research community. The Interdisciplinary Training Grant in Cancer Research supports two separate types of interdisciplinary trainees. The first are dual-mentor PhD candidates and postdoctoral fellows, who work within two separate research groups to study a common problem in cancer using unique, and yet complementary research disciplines. The second are graduate students who are enrolled in a dual-degree program that allows Ph.D. students in the Molecular and Cellular Biology (MCB) graduate program to earn a concurrent Masters of Science degree in Epidemiology. Trainees in either type of track are supported by this training grant as part of a broad initiative in Seattle to create a scientific culture where interdisciplinary cancer research and training is encouraged and fostered. Three separate institutions (The Fred Hutchinson Cancer Research Center, the University of Washington, and the Institute for Systems Biology) have served as research sites for IDTG trainees and their mentors. The IDTG faculty mentors each have primary appointments at one of those three institutions, and the majority have additional cross-institutional affiliate appointments within the UW graduate school and/or in the Seattle Cancer Consortium. We have created an environment across all these institutions where graduate students and postdoctoral fellows can become conversant in the goals, assumptions, logic, methods, and vocabulary of multiple research disciplines.
The IDTG is focused specifically on training graduate students and post-doctoral fellows in two or more cancer- related disciplines. It specifically supports the training of 'dual-mentored'graduate students and postdocs, who work on a research problem in cancer with two mentors who collaboratively supervise and direct complementary approaches to studying that problem, using tools and approaches from two separate research disciplines. The IDTG also supports training for students who are enrolled in a dual-degree program in Seattle that leads to a Masters degree in epidemiology ('MS Epi') and a PhD in Molecular and Cellular Biology (MCB). Over the past ten years, the IDTG has provided support for 54 past trainees and 9 current trainees. Almost all of the past trainees are still working in cancer-related research and/or patient care: 10% as academic faculty, another 25% as staff scientists, 25% in biotechnology and industry, and the remainder either as cancer physicians or as continuing graduate or postdoctoral fellows.
|Stewart, Mikaela D; Ritterhoff, Tobias; Klevit, Rachel E et al. (2016) E2 enzymes: more than just middle men. Cell Res 26:423-40|
|Poudel, Kumud R; Dong, Yongming; Yu, Hang et al. (2016) A time course of orchestrated endophilin action in sensing, bending, and stabilizing curved membranes. Mol Biol Cell 27:2119-32|
|Riggle, Kevin M; Turnham, Rigney; Scott, John D et al. (2016) Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma. Pediatr Blood Cancer 63:1163-7|
|Jordan-Williams, Kimberly L; Ramanujam, Neela; Farr, Andrew G et al. (2016) The Lymphatic Endothelial mCLCA1 Antibody Induces Proliferation and Growth of Lymph Node Lymphatic Sinuses. PLoS One 11:e0156079|
|Dingens, Adam S; Fairfortune, Tessa S; Reed, Susan et al. (2016) Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth 16:278|
|ÃsbjÃ¶rnsdÃ³ttir, Kristjana H; Hughes, James P; Wamalwa, Dalton et al. (2016) Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children. AIDS 30:2835-2843|
|Habenicht, Lauren M; Albershardt, Tina C; Iritani, Brian M et al. (2016) Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy. Oncoimmunology 5:e1204505|
|Bender Ignacio, Rachel A; Lee, Jeannette Y; Rudek, Michelle A et al. (2016) Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. J Acquir Immune Defic Syndr 72:52-7|
|Riggle, Kevin M; Riehle, Kimberly J; Kenerson, Heidi L et al. (2016) Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr Res 80:110-8|
|Anderson, Sarah; Poudel, Kumud Raj; Roh-Johnson, Minna et al. (2016) MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation. Proc Natl Acad Sci U S A 113:E5481-90|
Showing the most recent 10 out of 142 publications